Type in product code or name:
Code | Name | Applications | Availability | Size | Tested species | Price | Grade | |
---|---|---|---|---|---|---|---|---|
EB06769 | Goat Anti-Neuropeptide Y receptor Y5 Antibody | Pep-ELISA, WB, IP, IHC | ![]() |
100µg specific antibody in 200µl | Human, Hamster | $392.00 | ![]() |
|
Ordering Information forOrder direct from Everest
$73.00: Overnight shipping (not applicable to SB-shifix) to United States of America
Sent via overnight courier arrives approximately next day to mainland USA. Please note that your order will be shipped by our US partner Abcore LLC. Order offlineNow shipping direct to US customers! 99% of products are held in stock for immediate shipment, see individual product pages for availability. Please order through the US Dollar shopping cart (links on each product page) or we accept orders by email (usasales@everestbiotech.com), fax (888-841-9041), phone (888-320-4628). Please include the following information with your order:
In stock orders received by 13.30 PST on Monday through Thursday are shipped the same day. Orders are shipped by our US logistics partner Abcore LLC.
OR
Order from our local distributorARP American Research Products, IncARP American Research Products, Inc |
Peptide with sequence C-GLSNKENRLEEN, from the internal region of the protein sequence according to NP_006165.1.
Please note the peptide is available for sale.
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing.
Immunoprecipitation: Customer feedback showed specific results when this product was used in IP. This antibody has been successfully used in IP: PMID: 30503694.
This antibody has been successfully used in the following paper:
Congyi Lu et al.
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Nat Commun. 2022 Apr 28;13(1):2323.
PMID: 35484119
This antibody has been successfully used in WB on Human:
Nouran Abualsaud, Lindsay Caprio, Susana Galli, Ewa Krawczyk, Lamia Alamri, Shiya Zhu, G Ian Kitlinska
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation
Front Cell Dev Biol. 2021 Feb 17;8:627090.
PMID: 33681186
This antibody has been successfully used in WB and IP on CHO-K1 cells:
Magdalena Czarneckaa, Congyi Lua,b, Jennifer Ponsa, Induja Maheswarana, Pawel Ciborowskic, Lihua Zhangd, Amrita Cheemad, Joanna Kitlinskaa
Neuropeptide Y receptor interactions regulate its mitogenic activity
Neuropeptides. 2019 Feb;73:11-24.
PMID: 30503694
This antibody has been successfully used in WB on Human:
Czarnecka M, Kitlinska J.
Cell Surface Protein Detection to Assess Receptor Internalization.
Bio Protoc. 2016 Oct 20;6(20)
PMID: 28413811
This antibody has been successfully used in WB on Human:
Sheriff S, Ali M, Yahya A, Haider KH, Balasubramaniam A, Amlal H.
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Mol Cancer Res. 2010 Apr;8(4):604-14.
PMID: 20332211